Robert D. Dayton

1.7k total citations
35 papers, 1.3k citations indexed

About

Robert D. Dayton is a scholar working on Cellular and Molecular Neuroscience, Neurology and Genetics. According to data from OpenAlex, Robert D. Dayton has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 13 papers in Neurology and 11 papers in Genetics. Recurrent topics in Robert D. Dayton's work include Virus-based gene therapy research (11 papers), Amyotrophic Lateral Sclerosis Research (9 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Robert D. Dayton is often cited by papers focused on Virus-based gene therapy research (11 papers), Amyotrophic Lateral Sclerosis Research (9 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Robert D. Dayton collaborates with scholars based in United States, Canada and Finland. Robert D. Dayton's co-authors include Ronald L. Klein, David B. Wang, Kasey L. Jackson, Richard M. Zweig, Nancy J. Leidenheimer, Todd E. Golde, Karen Jansen, Dennis W. Dickson, Elysse A. Orchard and Benjamin E. Deverman and has published in prestigious journals such as PLoS ONE, Scientific Reports and Brain Research.

In The Last Decade

Robert D. Dayton

35 papers receiving 1.3k citations

Peers

Robert D. Dayton
Comparison fields: 5 of 82
  • Molecular Biology 682
  • Genetics 453
  • Neurology 380
  • Cellular and Molecular Neuroscience 354
  • Physiology 235
Lynsey Bilsland United Kingdom
Tomohiro Kabuta Japan
Rim Amouri Tunisia
Michael Bidinosti Canada
Hong‐Fu Li China
Patrizia Amati‐Bonneau France
Erkang Fei China
Adam K. Bevan United States
Andreas Puschmann Sweden
Sandro Alves France
Lynsey Bilsland United Kingdom View profile →
Citations per field, relative to Robert D. Dayton
Robert D. Dayton · 1×
Citations per year, relative to Robert D. Dayton
Robert D. Dayton · 1×

Countries citing papers authored by Robert D. Dayton

Since Specialization
Citations

This map shows the geographic impact of Robert D. Dayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Dayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Dayton more than expected).

Fields of papers citing papers by Robert D. Dayton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Dayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Dayton. The network helps show where Robert D. Dayton may publish in the future.

Co-authorship network of co-authors of Robert D. Dayton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. Dayton. A scholar is included among the top collaborators of Robert D. Dayton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. Dayton. Robert D. Dayton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Highly socially vulnerable communities exhibit disproportionately increased viral loads as measured in community wastewater Environmental Research Robert D. Dayton, Aaron Bivins et al. 9
2 TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia Scientific Reports Hilary C. Archbold, Kasey L. Jackson et al. 107
3 More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose–response and comparison to AAV PHP.B Gene Therapy Robert D. Dayton, Ronald L. Klein et al. 47
4 p62 Pathology Model in the Rat Substantia Nigra with Filamentous Inclusions and Progressive Neurodegeneration PLoS ONE Kasey L. Jackson, Wen-Lang Lin et al. 14
5 Entorhinal tau pathology disrupts hippocampal-prefrontal oscillatory coupling during associative learning Neurobiology of Aging Mark D. Morrissey, Robert D. Dayton et al. 28
6 Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction Journal of Visualized Experiments Kasey L. Jackson, Robert D. Dayton et al. 5
7 Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis Gene Therapy Kasey L. Jackson, Robert D. Dayton et al. 60
8 The advent of AAV9 expands applications for brain and spinal cord gene delivery Expert Opinion on Biological Therapy Robert D. Dayton, David B. Wang et al. 111
9 Frontotemporal lobar degeneration-related proteins induce only subtle memory-related deficits when bilaterally overexpressed in the dorsal hippocampus Experimental Neurology Robert D. Dayton, David B. Wang et al. 12
10 Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory response Experimental Neurology David B. Wang, Robert D. Dayton et al. 20
11 Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system Experimental Neurology Michael F. Salvatore, Greg A. Gerhardt et al. 35
12 Mimicking Aspects of Frontotemporal Lobar Degeneration and Lou Gehrig's Disease in Rats via TDP-43 Overexpression Molecular Therapy David B. Wang, Robert D. Dayton et al. 70
13 PET imaging in rats to discern temporal onset differences between 6-hydroxydopamine and tau gene vector neurodegeneration models Brain Research Ronald L. Klein, Robert D. Dayton et al. 7
14 Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer Neurobiology of Aging Ronald L. Klein, Robert D. Dayton et al. 33
15 Tau expression levels from various adeno‐associated virus vector serotypes produce graded neurodegenerative disease states European Journal of Neuroscience Ronald L. Klein, Robert D. Dayton et al. 42
16 AAV8, 9, Rh10, Rh43 Vector Gene Transfer in the Rat Brain: Effects of Serotype, Promoter and Purification Method Molecular Therapy Ronald L. Klein, Robert D. Dayton et al. 161
17 Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model Neuroscience Letters Ronald L. Klein, Robert D. Dayton et al. 42
18 Efficient Neuronal Gene Transfer with AAV8 Leads to Neurotoxic Levels of Tau or Green Fluorescent Proteins Molecular Therapy Ronald L. Klein, Robert D. Dayton et al. 165
19 Long-Term Dietary Habits Affect Soy Isoflavone Metabolism and Accumulation in Prostatic Fluid in Caucasian Men Journal of Nutrition Tammy E. Hedlund, Paul Maroni et al. 80
20 Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat Neurobiology of Disease Ronald Klein, Robert D. Dayton et al. 31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026